GN1019C - TASQ debrief
Research type
Research Study
Full title
Concept Confirmation of the TASQ in Early Breast Cancer Patients
IRAS ID
238167
Contact name
Jason Randall
Contact email
Sponsor organisation
Clinical outcome Solutions
Duration of Study in the UK
0 years, 1 months, 21 days
Research summary
The purpose of conducting this research is to explore treatment satisfaction in individuals diagnosed with early breast cancer whilst also exploring patient understanding of a questionnaire designed to capture treatment satisfaction. \n\nParticipants will take part in one face-to-face interview for approximately 60 minutes. The first part of the interview will be a brief discussion around treatment of their early breast cancer, and how satisfied they are with their treatment. The second part of the interview will involve a discussion around the patients understanding of a questionnaire designed to capture treatment satisfaction. This will involve discussion around if it makes sense to the patients, what it was like to compleate, if it captured everything they thought was important to treatment satisfaction, if the response options were adequate and if the recall period was suitable. It is anticipated that approximately 20 patients will take part in this study.
REC name
West of Scotland REC 3
REC reference
17/WS/0260
Date of REC Opinion
18 Jan 2018
REC opinion
Further Information Favourable Opinion